Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja B Grammer

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
BMC Medical Genetics|November 11, 2010
Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)Marcus E Kleber, Tanja B Grammer, Wilfried Renner, et al.
Drugs|April 3, 2014
Dusty punch cards and an eternal enigma: high-density lipoproteins and atherosclerosisMarcus E Kleber, Tanja B Grammer, Ursula Kassner, et al.
Clinical Chemistry and Laboratory Medicine|May 18, 2011
High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC StudyBoris T Ivandic, Eberhard Spanuth, Marcus Kleber, et al.
Thrombosis and Haemostasis|March 11, 2010
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markersKatharina Schroecksnadel, Tanja B Grammer, Bernhard O Boehm, et al.
Diabetes Care|April 26, 2011
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiographyGuenther Silbernagel, Tanja B Grammer, Bernhard R Winkelmann, et al.
Clinical Chemistry|April 28, 2009
Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health studyTanja B Grammer, Dietmar Fuchs, Bernhard O Boehm, et al.
European Heart Journal|May 24, 2008
C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC studyTanja B Grammer, Winfried März, Wilfried Renner, et al.
European Journal of Clinical Investigation|January 15, 2015
Low serum tryptophan predicts higher mortality in cardiovascular diseaseChristian Murr, Tanja B Grammer, Marcus E Kleber, et al.
Journal of Amino Acids|March 25, 2014
Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health studyChristian Murr, Tanja B Grammer, Andreas Meinitzer, et al.
Diabetes Care|July 1, 2011
Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic womenElisabeth Wehr, Stefan Pilz, Bernhard O Boehm, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
BMC Medical Genetics|November 11, 2010
Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)Marcus E Kleber, Tanja B Grammer, Wilfried Renner, et al.
Drugs|April 3, 2014
Dusty punch cards and an eternal enigma: high-density lipoproteins and atherosclerosisMarcus E Kleber, Tanja B Grammer, Ursula Kassner, et al.
Clinical Chemistry and Laboratory Medicine|May 18, 2011
High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC StudyBoris T Ivandic, Eberhard Spanuth, Marcus Kleber, et al.
Thrombosis and Haemostasis|March 11, 2010
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markersKatharina Schroecksnadel, Tanja B Grammer, Bernhard O Boehm, et al.
Diabetes Care|April 26, 2011
Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiographyGuenther Silbernagel, Tanja B Grammer, Bernhard R Winkelmann, et al.
Clinical Chemistry|April 28, 2009
Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health studyTanja B Grammer, Dietmar Fuchs, Bernhard O Boehm, et al.
European Heart Journal|May 24, 2008
C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC studyTanja B Grammer, Winfried März, Wilfried Renner, et al.
European Journal of Clinical Investigation|January 15, 2015
Low serum tryptophan predicts higher mortality in cardiovascular diseaseChristian Murr, Tanja B Grammer, Marcus E Kleber, et al.
Journal of Amino Acids|March 25, 2014
Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health studyChristian Murr, Tanja B Grammer, Andreas Meinitzer, et al.
Diabetes Care|July 1, 2011
Low free testosterone levels are associated with all-cause and cardiovascular mortality in postmenopausal diabetic womenElisabeth Wehr, Stefan Pilz, Bernhard O Boehm, et al.
Pageof 9